Bio-Techne Newsroom

Citi Downgrades Bio-Techne to Neutral, Cites Valuation

Seeking AlphaMay 22 14:34 ET

Bio-Techne Analyst Ratings

BenzingaMay 22 08:38 ET

Citigroup Downgrades Bio-Techne to Neutral From Buy, With $85 Price Target

MT NewswiresMay 22 05:54 ET

Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating

MT NewswiresMay 6 05:58 ET

Benchmark Reiterates Buy on Bio-Techne, Maintains $95 Price Target

BenzingaMay 2 09:56 ET

Analysts' Top Healthcare Picks: Bio-Techne (TECH), Gilead Sciences (GILD)

TipRanksMay 2 09:45 ET

RBC Capital Adjusts Price Target on Bio-Techne to $72 From $71, Sector Perform Rating Kept

MT NewswiresMay 2 08:18 ET

Bio-Techne Analyst Ratings

BenzingaMay 2 06:52 ET

Baird Maintains Outperform on Bio-Techne, Raises Price Target to $81

BenzingaMay 2 06:52 ET

KeyBanc Remains a Buy on Bio-Techne (TECH)

TipRanksMay 2 04:10 ET

Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Amneal Pharmaceuticals (AMRX)

TipRanksMay 2 04:05 ET

Deutsche Bank Adjusts Price Target on Bio-Techne to $84 From $82

MT NewswiresMay 1 11:12 ET

RBC Capital Sticks to Its Hold Rating for Bio-Techne (TECH)

TipRanksApr 30 21:50 ET

RBC Capital Adjusts Price Target on Bio-Techne to $71 From $79

MT NewswiresApr 29 09:42 ET

Navigating 4 Analyst Ratings For Bio-Techne

BenzingaApr 18 12:06 ET

Bio-Techne Analyst Ratings

BenzingaApr 18 08:14 ET

RBC Capital Reaffirms Their Hold Rating on Bio-Techne (TECH)

TipRanksApr 8 21:52 ET

RBC Raises Price Target on Bio-Techne to $79 From $75, Keeps Sector Perform Rating

MT NewswiresApr 8 07:47 ET

Bio-Techne: Solid Consumables Business and Strategic Investments Anchor Buy Rating Amid Sector Headwinds

TipRanksFeb 5 04:05 ET

Stifel Downgrades Bio-Techne to Hold, Cites Near-term Growth

Seeking AlphaFeb 2 15:28 ET